MX173727B - Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante - Google Patents

Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante

Info

Publication number
MX173727B
MX173727B MX022409A MX2240990A MX173727B MX 173727 B MX173727 B MX 173727B MX 022409 A MX022409 A MX 022409A MX 2240990 A MX2240990 A MX 2240990A MX 173727 B MX173727 B MX 173727B
Authority
MX
Mexico
Prior art keywords
anticoagulant
pharmaceutical composition
oral pharmaceutical
low dosage
platelet inhibitor
Prior art date
Application number
MX022409A
Other languages
English (en)
Inventor
William Joseph Addicks
Joseph A Mollica
Gary Howard Slatko
Original Assignee
E I Du Pont De Nemorus And Com
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E I Du Pont De Nemorus And Com filed Critical E I Du Pont De Nemorus And Com
Publication of MX173727B publication Critical patent/MX173727B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una composición farmaceutica que tuene un efcto inhibitorio sobre la formación de trombos y enla agrgación de plaquetas, caracterizada porque comprende un portrador farmaceutico adecuado y una combinación de ingredientes acativos que consisiten en warfrina o una sal farm euticamente aceptable de la misma presente en una cantidad que va a ser liberada, de aproximadamente 0.5 a 10 mg y ácido acetilsalicólico presente en una cantidad que va a ser liberada, de aproximadamente 20.0 a 325.0 mg.
MX022409A 1989-09-18 1990-09-17 Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante MX173727B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (1)

Publication Number Publication Date
MX173727B true MX173727B (es) 1994-03-24

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
MX022409A MX173727B (es) 1989-09-18 1990-09-17 Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante

Country Status (22)

Country Link
US (1) US5041430A (es)
EP (1) EP0493408B1 (es)
JP (1) JPH05501109A (es)
KR (1) KR950008307B1 (es)
AT (1) ATE137972T1 (es)
AU (1) AU635881B2 (es)
CA (1) CA2065347A1 (es)
CZ (1) CZ454090A3 (es)
DE (1) DE69027036D1 (es)
FI (1) FI921134A (es)
GR (1) GR1001131B (es)
HU (1) HUT62488A (es)
IE (1) IE903356A1 (es)
IL (1) IL95721A (es)
LV (1) LV10050B (es)
MA (1) MA21953A1 (es)
MX (1) MX173727B (es)
NO (1) NO920946L (es)
NZ (1) NZ235337A (es)
PT (1) PT95343B (es)
WO (1) WO1991004031A1 (es)
ZA (1) ZA907431B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
CA2218696A1 (en) * 1995-04-19 1996-10-24 L. Jackson Ii Roberts Compositions, kits and methods for administration of antilipemic and an ti-platelet aggregation drugs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
AU2002306461A1 (en) * 2001-03-28 2002-10-15 Rheologics, Inc. In vivo delivery methods and compositions
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
EP1589930A2 (en) * 2003-01-08 2005-11-02 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
EA200600626A1 (ru) * 2003-10-20 2007-02-27 Тева Фармасьютикал Индастриес Лтд. Композиция и лекарственная форма продолжительного выделения леводопы
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
CA2566310C (en) * 2004-05-21 2014-05-13 Lawrence Solomon Scored pharmaceutical tablets comprising a plurality of segments
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
WO2008082542A1 (en) * 2006-12-19 2008-07-10 Institute For Therapeutic Research, Inc. Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
US20110041725A1 (en) * 2007-06-19 2011-02-24 Daniel Rittschof Anticoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ304136B6 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (es) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
DE2860430D1 (en) * 1977-10-08 1981-02-26 Beecham Group Ltd Antithrombotic compositions containing benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
ATE50497T1 (de) * 1984-07-21 1990-03-15 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.

Also Published As

Publication number Publication date
GR1001131B (el) 1993-04-28
NO920946D0 (no) 1992-03-11
WO1991004031A1 (en) 1991-04-04
MA21953A1 (fr) 1991-04-01
KR920703046A (ko) 1992-12-17
PT95343A (pt) 1991-08-14
IL95721A (en) 1995-07-31
ZA907431B (en) 1992-05-27
EP0493408A4 (en) 1992-10-07
CA2065347A1 (en) 1991-03-19
FI921134A0 (fi) 1992-03-17
US5041430A (en) 1991-08-20
ATE137972T1 (de) 1996-06-15
GR900100702A (en) 1992-01-20
LV10050B (en) 1995-02-20
NZ235337A (en) 1993-05-26
LV10050A (lv) 1994-05-10
KR950008307B1 (ko) 1995-07-27
EP0493408B1 (en) 1996-05-15
JPH05501109A (ja) 1993-03-04
IE903356A1 (en) 1991-04-10
DE69027036D1 (de) 1996-06-20
HUT62488A (en) 1993-05-28
EP0493408A1 (en) 1992-07-08
IL95721A0 (en) 1991-06-30
NO920946L (no) 1992-03-11
AU635881B2 (en) 1993-04-01
PT95343B (pt) 1998-06-30
AU6330690A (en) 1991-04-18
FI921134A (fi) 1992-03-17
CZ454090A3 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
MX173727B (es) Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
MX9202546A (es) Dimeros de rapamicina y composicion farmaceutica que los contiene.
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
FI955681A (fi) Masennuslääkkeen annostusmuoto
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
OA09123A (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ATE46265T1 (de) Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika.
FI893643A0 (fi) Farmaceutiska kompositioner.
IT8720771A0 (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
ES2062160T3 (es) Compuestos sustituidos de pirrolicina y su aplicacion en farmacia.
NO921223D0 (no) Kombinasjonspreparat med antitrombotisk virkning
NO894158L (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
MX9203624A (es) Derivados de benceno y composiciones farmaceuticas que los contienen.